Document is current
Any future updates will be listed below
-
Authors
Shorbaji, Khaled
Shedul, Gabriel L.
Ripiye, Nanna
Ojji, Dike
Hirschhorn, Lisa R.
Goss, Charles W.
Huffman, Mark D.
- License Information
-
More Information
Article History
Received: 22 June 2025
Accepted: 26 November 2025
First Online: 2 January 2026
Declarations
:
: Not applicable.
: Not applicable.
: MDH has received travel support from the World Heart Federation and consulting fees from PwC Switzerland. MDH has pending patents for heart failure polypills. MDH has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. The remaining authors declare no competing interests.
